Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver

13 Aug 2021

Abstract excerpt

The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) as multifactorial chronic liver disease and the lack of a specific treatment have begun a new era in its treatment using gene expression changes and microRNAs. This study aimed to investigate the potential therapeutic effects of natural compounds in NAFLD by regulating miRNA expression. MicroRNAs play essential roles in regulating the cell's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Liver Disease Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34426744
DOI: 10.1155/2021/6641031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty LiverPMID 34426744Read ↗

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

miRNAs and NAFLD: from pathophysiology to therapySemantic proximity Read ↗

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read ↗

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular DiseaseSemantic proximity Read ↗

Dual Role of MicroRNAs in NAFLDSemantic proximity Read ↗

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesSemantic proximity Read ↗

Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsSemantic proximity Read ↗

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity Read ↗

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewSemantic proximity Read ↗

MicroRNAs in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.